ArticleFrontiers in nutrition2025
Development and validation of age- and sex-specific reference intervals for serum vitamin B5 in Henan pediatric population by LC-MS/MS.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Reference intervals (RIs) for serum vitamin B5 (pantothenic acid, B5) specific to the Henan pediatric population have not been established. Current clinical practice, in China continues to rely on reference thresholds derived from international populations. However, these generalized intervals may lack diagnostic accuracy and relevance when applied to domestic children. This study aims to establish age- and sex-specific RIs for serum B5 in Henan children aged 1-17 years, thereby enhancing the reliability of clinical assessments and nutritional evaluations. Methods: This cross-sectional study involved 1,998 healthy children who underwent routine physical examinations between January 2022 and March 2025. Serum B5 concentrations were quantified using liquid chromatography-tandem mass spectrometry (LC-MS/MS) system. Data exhibiting non-normal distribution are expressed as median and interquartile range (IQR) [M (P Results: Age and sex were identified as significant factors influencing serum B5 concentrations in the pediatric cohort. The study population had a predominance proportion of male participants (59.01%, 1,179/1,998), and most subjects were under the age of 12, reflecting a primarily prepubescent sample (93.59%, 1,870/1,970). Based on these demographic characteristics, further stratified analyses were conducted to establish age- and sex-specific RIs for serum B5 levels. For male children, the RIs were 31.57-169.31 ng/mL for the 1-5-year age group, 24.23-127.57 ng/mL for those aged 6-11 years, and 25.36-95.37 ng/mL for those aged 12 and older. Female participants showed RIs of 31.10-166.20 ng/mL, 23.93-114.79 ng/mL, and 18.56-122.55 ng/mL for the same age categories. These stratified intervals highlight the importance of considering both age and sex in the clinical interpretation of pediatric B5 measurements. Validation results confirmed the reliability of the established reference intervals, demonstrating a minimum conformity rate of 93.94%, which meets the 90% threshold stipulated by Chinese industry standards. Conclusion: This study provides the first comprehensive set of age- and sex-specific RIs for serum B5 in Chinese children aged 1-17 years and has validated them in a representative cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.